Consideration from the Smallest Starting Dose Used in Clinical Trials and the Approved Minimum Clinical Dose for Microdose of Antibody Pharmaceuticals in Japan
{"title":"Consideration from the Smallest Starting Dose Used in Clinical Trials and the Approved Minimum Clinical Dose for Microdose of Antibody Pharmaceuticals in Japan","authors":"Yasuhiro Suzuki, K. Matsuno, A. Inano","doi":"10.3999/jscpt.51.1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21491,"journal":{"name":"Rinsho Yakuri\\/japanese Journal of Clinical Pharmacology and Therapeutics","volume":"32 1","pages":"1-10"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rinsho Yakuri\\/japanese Journal of Clinical Pharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3999/jscpt.51.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
